Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

FDA & EMA

FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma

ONCOLife

Reengineering CAR-T Cells to Last Longer in the Fight Against Cancer and HIV

ONCOLife

Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity

ONCOLife

PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%

Clinical Trials

TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias

ONCOLife

Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer

ONCOLife

Colibactin’s Molecular Blueprint Exposes How a Gut Microbial Toxin Triggers Colorectal Cancer

ONCOLife Issues

Featured Articles

TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer

20 March 2026

Phase 3 TALAPRO-3 results show that talazoparib plus enzalutamide significantly improves radiographic progression-free survival in HRR-mutated metastatic castration-sensitive prostate cancer, exceeding the target hazard ratio. Benefits were consistent across B...

Trending Articles

Ribociclib Maintains Long-Term Disease Control in HR+ HER2 Metastatic Breast Cancer

Preoperative Radiation May Improve Immune Response in HR+ HER2- Breast Cancer

Clinical Trials

11 December 2025

Tucatinib Combination Cuts Progression Risk by 36% in HER2+ Metastatic Breast Cancer

Clinical Trials

10 December 2025

Giredestrant Cuts Risk of Invasive Recurrence by 30% in Early ER+ Breast Cancer

Clinical Trials

10 December 2025

CAR T Anito cel Delivers Deep, Durable Responses in R&R Multiple Myeloma

ONCOLife

9 December 2025

Lunsumio Combo Deliver High Response Rates in Follicular and Large B-Cell Lymphomas

Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies

Biotech

2 December 2025

Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery

ONCOLife

2 December 2025

Enozertinib Shows Strong Systemic and CNS Activity in EGFR Exon 20+ NSC Lung Cancer

Clinical Trials

6 December 2025

Blood-Based cfDNA Test Demonstrates Potential for Detecting Lung Cancer in Nonsmokers

ONCOLife

5 December 2025

FDA Approves Durvalumab as First Perioperative Immunotherapy for GEJ Cancers

FDA Approves Keytruda–Padcev Combo as First Perioperative Treatment for Bladder Cancer

FDA & EMA

24 November 2025

Sevabertinib Wins FDA Approval with Strong Responses in HER2+ NSC Lung Cancer

FDA & EMA

20 November 2025

FDA Approves Epcoritamab-bysp as the First Bispecific Antibody for Follicular Lymphoma

FDA & EMA

19 November 2025

FDA Approves Ziftomenib as a New Targeted Option for NPM1+ Acute Myeloid Leukemia

FDA & EMA

14 November 2025